Narcolepsy
Not recruitingStudy on the Safety and Effectiveness of ALKS 2680 for Patients with Narcolepsy Type 2
- Disease:Narcolepsy
- Substances:Alks 2680
Belgium- Participants:18–64 years · 65+ years
- Substances:Alks 2680
- Sponsor:Alkermes Inc.
Rare diseases
Investigational molecules
Locations
Back to Belgium157 clinical trials in Namur, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on respiratory conditions including evaluation of vaccines against RSV, influenza, and treatments for chronic cough and asthma.
Research emphasizes preventive care and management of respiratory infections in vulnerable populations.
Comprehensive studies examining new treatments for various types of cancer, with particular focus on breast, lung, and head and neck cancers.
Trials evaluate novel therapeutic combinations and targeted treatments for specific cancer types.
Investigation of treatments for various chronic diseases including kidney disease, narcolepsy, and chronic rhinosinusitis.
Focus on improving quality of life and disease management for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.